SHetA2 treatment of endometrial cancer cells disrupted mortalin binding to metabolic enzymes, aldehyde dehydrogenase 18 family member A1 (ALDH18A1), cytidine triphosphate synthetase (CTPS), malate dehydrogenase (MDH1), and enoyl coenzyme A hydratase, short chain, 1, mitochondrial (ECHS1) (Chandra et al., 2021). Here, ALDH18A1 is linked to endometrial cancer.